EP
IMGN

Eversept Partners’s Immunogen Inc IMGN Stock Holding History

Eversept Partners’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-748,950
Closed -$22.2M – 74
2023
Q4 		$22.2M Buy
+748,950
New +$14.9M 1.95% 16

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Eversept Partners's IMGN Position: Q1 2024 in Review

Eversept Partners sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 748,950 shares — an estimated $22.2M sold.

Eversept Partners first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $22.2M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Eversept Partners reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Eversept Partners sold 748,950 Immunogen Inc shares in Q1 2024, an estimated $22.2M.
  • Eversept Partners first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Eversept Partners's Immunogen Inc position peaked at $22.2M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Eversept Partners's 13F filing for Q1 2024, filed 15 May 2024.